Title: Design, synthesis and biological evaluation of antimicrobial diarylimine and –amine compounds targeting the interaction between the bacterial NusB and NusE proteins
Authors: Qiu, Y 
Chan, ST 
Lin, L
Shek, TL
Tsang, TF
Barua, N
Zhang, Y
Ip, M
Chan, PKS
Blanchard, N
Hanquet, G
Zuo, Z
Yang, X
Ma, C 
Issue Date: 15-Sep-2019
Source: European journal of medicinal chemistry, 15 Sept. 2019, v. 178, p. 214-231
Abstract: Discovery of antimicrobial agents with a novel model of action is in urgent need for the clinical management of multidrug-resistant bacterial infections. Recently, we reported the identification of a first-in-class bacterial ribosomal RNA synthesis inhibitor, which interrupted the interaction between the bacterial transcription factor NusB and NusE. In this study, a series of diaryl derivatives were rationally designed and synthesized based on the previously established pharmacophore model. Inhibitory activity against the NusB-NusE binding, circular dichroism of compound treated NusB, antimicrobial activity, cytotoxicity, hemolytic property and cell permeability using Caco-2 cells were measured. Structure-activity relationship and quantitative structure–activity relationship were also concluded and discussed. Some of the derivatives demonstrated improved antimicrobial activity than the hit compound against a panel of clinically important pathogens, lowering the minimum inhibition concentration to 1–2 μg/mL against Staphylococcus aureus, including clinical strains of methicillin-resistant Staphylococcus aureus at a level comparable to some of the marketed antibiotics. Given the improved antimicrobial activity, specific inhibition of target protein-protein interaction and promising pharmacokinetic properties without significant cytotoxicity, this series of diaryl compounds have high potentials and deserve for further studies towards a new class of antimicrobial agents in the future.
Keywords: Antimicrobial activity
Diarylamine
Diarylimine
Inhibitor
Methicillin-resistant Staphylococcus aureus
Protein-protein interaction
Publisher: Elsevier Masson
Journal: European journal of medicinal chemistry 
ISSN: 0223-5234
EISSN: 1768-3254
DOI: 10.1016/j.ejmech.2019.05.090
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.